B+
Overall grade
B+
Financial quality
The sleeper story is THC's cash flow machine - they've automated denial responses and shortened collection cycles while the industry struggles with payer disputes, driving a $250M FCF guidance raise that nobody's talking about. The obvious headline is another guidance beat, but the real story is they're front-loading CapEx ahead of potential ACA subsidy chaos, betting $150M extra on capacity expansion while competitors wait and see. The binding constraint is now capacity, not demand - USPI volume growth finally turned positive but management got weirdly defensive about Q4 deceleration, suggesting they're hitting utilization limits. Saum's dismissive 'it's just math basically' when pressed on the slowdown was uncharacteristically evasive. My view changes if Q4 USPI results come in below the implied ~8% growth rate, which would signal demand issues rather than capacity constraints.
The 30-second version
- CapEx surge (+$150M raise) signals aggressive capacity expansion ahead of potential ACA subsidy chaos
- Free cash flow machine firing on all cylinders with Conifer collections driving $250M guidance raise
- USPI volume growth finally turned positive but guidance implies Q4 deceleration to ~8% from mid-teens pace
What changed this quarter
| Metric | Prior | This quarter |
|---|---|---|
| Revenue | $5.3B (19% YoY growth in Q2) | $5.3B (solid growth) |
| Adj EBITDA | $1.121B (19% YoY growth) | $1.1B (12% YoY growth) |
| Adj EBITDA Margin | 21.3% (+280 bps YoY) | 20.8% (+170 bps YoY) |
| USPI Adj EBITDA | $498M (11% YoY growth) | $492M (12% YoY growth) |
| USPI Same-Facility Revenue Growth | 7.7% | 8.3% |
| USPI Case Volumes | -0.6% (declining) | +2.1% same-facility |
| Hospital Adj EBITDA | $623M (25% YoY growth) | $607M (13% YoY growth) |
| Hospital Admissions | +1.6% same-store | +1.4% same-store |
Accountability tracked
7 new promises made4 narrative shifts flagged6 prior promises graded
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Subscribe to Call Sheet Daily →